GreenLight Biosciences (GRNA)
NASDAQ: GRNA
· Real-Time Price · USD
0.30
0.00 (0.13%)
At close: Jul 21, 2023, 10:00 PM
GreenLight Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 10.2M | 6.64M | 3.69M | 2M | 257K | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 10.2M | 6.64M | 3.69M | 2M | 257K | n/a | n/a | n/a | n/a |
Operating Income | -155.43M | -163.92M | -63.23M | -54.4M | -28.89M | -13.1M | -92M | -64.59M | -38.14M |
Interest Income | 1.49M | 895K | 293.39K | 57.39K | 5.39K | 12.39K | 29K | 25K | 20K |
Pretax Income | -156.22M | -165.96M | -64.62M | -56.74M | -31.98M | -15.06M | -95.13M | -65.94M | -38.77M |
Net Income | -158.07M | -168.59M | -66.04M | -57.06M | -32.34M | -15.06M | -95.13M | -65.94M | -38.77M |
Selling & General & Admin | 35.12M | 55.2M | 45.78M | 42.87M | 38.22M | 13.1M | 17.41M | 12.3M | 7.36M |
Research & Development | 129.7M | 114.54M | 82.11M | 74.82M | 52.68M | 62.08M | 76.05M | 53.38M | 31.38M |
Other Expenses | -139K | -396K | -320K | -277K | -257K | n/a | n/a | n/a | n/a |
Operating Expenses | 164.68M | 169.34M | 66.66M | 56.15M | 28.89M | 13.1M | 92M | 64.59M | 38.14M |
Interest Expense | 4.06M | 4.12M | 3.48M | 3.04M | 2.23M | 1.47M | 1.79M | 1.16M | 635K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 164.68M | 169.34M | 66.66M | 56.15M | 28.89M | 13.1M | 92M | 64.59M | 38.14M |
Income Tax Expense | 1.85M | 2.63M | -46.39K | -507.39K | 55.61K | 7.61K | 1.79M | 1.16M | 635K |
Shares Outstanding (Basic) | 151.61M | 131.98M | 139.06M | 123.25M | 113.56M | n/a | 96.42M | 96.42M | 96.42M |
Shares Outstanding (Diluted) | 151.61M | 131.98M | 139.06M | 123.25M | 113.56M | n/a | 96.42M | 96.42M | 96.42M |
EPS (Basic) | -1.17 | -1.33 | -1.03 | -1.06 | -0.92 | -0.8 | -0.8 | -0.5 | -0.22 |
EPS (Diluted) | -1.17 | -1.33 | -1.03 | -1.06 | -0.92 | -0.8 | -0.8 | -0.5 | -0.22 |
EBITDA | -146.69M | -156.01M | -58.39M | -50.18M | -23.54M | -8.72M | -87.68M | -61.65M | -36.39M |
EBIT | -152.17M | -161.84M | -123.72M | -115.64M | -93.66M | -77.5M | -94.35M | -66.43M | -37.82M |
Depreciation & Amortization | 8.74M | 7.91M | 4.84M | 4.21M | 5.35M | 4.36M | 4.29M | 2.92M | 1.73M |